You have free access to this content

Liver International

Cover image for Vol. 33 Issue s1

Special Issue: Proceedings of the 6th Paris Hepatitis Conference, International Conference on the Management of Patients with Viral Hepatitis

February 2013

Volume 33, Issue Supplement s1

Pages 1–199

  1. Proceedings of the 6th Paris Hepatitis Conference, International Conference on the Management of Patients with Viral Hepatitis, 14-15 January 2013, Paris, France. The publication of this supplement was supported by Roche, Janssen, Gilead, MSD, Novartis, BMS

    1. Top of page
    2. Proceedings of the 6th Paris Hepatitis Conference, International Conference on the Management of Patients with Viral Hepatitis, 14-15 January 2013, Paris, France. The publication of this supplement was supported by Roche, Janssen, Gilead, MSD, Novartis, BMS
    3. Review Articles
    1. Editorial

      You have free access to this content
      Treatment of viral hepatitis: a new era (pages 1–2)

      Patrick Marcellin and Tarik Asselah

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12086

  2. Review Articles

    1. Top of page
    2. Proceedings of the 6th Paris Hepatitis Conference, International Conference on the Management of Patients with Viral Hepatitis, 14-15 January 2013, Paris, France. The publication of this supplement was supported by Roche, Janssen, Gilead, MSD, Novartis, BMS
    3. Review Articles
    1. You have free access to this content
      Optimal treatment with telaprevir for chronic HCV infection (pages 3–13)

      Arun B. Jesudian and Ira M. Jacobson

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12079

    2. You have free access to this content
      Optimal treatment with boceprevir for chronic HCV infection (pages 14–22)

      Benjamin Maasoumy and Michael P. Manns

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12070

    3. You have free access to this content
    4. You have free access to this content
      How to optimize HCV therapy in genotype 1 patients: management of side-effects (pages 30–34)

      Angeli Chopra, Patricia L. Klein, Thia Drinnan and Samuel S. Lee

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12080

    5. You have free access to this content
      How to optimize HCV therapy in genotype 2 patients (pages 35–40)

      Eleonora Grassi and Alessio Aghemo

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12056

    6. You have free access to this content
      How to optimize HCV therapy in genotype 4 patients (pages 41–45)

      Gamal Esmat, Mohamed El Kassas, Mohamed Hassany, Mohamed Esmat Gamil and Maisa El Raziky

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12059

    7. You have free access to this content
      How to optimize HCV therapy in genotype 1 patients with cirrhosis (pages 46–55)

      Marc Bourlière, Astrid Wendt, Hélène Fontaine, Christophe Hézode, Stanislas Pol and Jean Pierre Bronowicki

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12067

    8. You have free access to this content
    9. You have free access to this content
      HCV therapy in HIV-infected patients (pages 63–67)

      Mark S. Sulkowski

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12082

    10. You have free access to this content
      Best strategies for global HCV eradication (pages 68–79)

      Liesl M. Hagan and Raymond F. Schinazi

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12063

    11. You have free access to this content
      New therapeutic strategies in HCV: second-generation protease inhibitors (pages 80–84)

      Virginia C. Clark, Joy A. Peter and David R. Nelson

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12061

    12. You have free access to this content
      New therapeutic strategies in HCV: polymerase inhibitors (pages 85–92)

      Ludmila Gerber, Tania M. Welzel and Stefan Zeuzem

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12068

    13. You have free access to this content
      Interferon free therapy with direct acting antivirals for HCV (pages 93–104)

      Tarik Asselah and Patrick Marcellin

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12076

    14. You have free access to this content
      Patients with HCV and F1 and F2 fibrosis stage: treat now or wait? (pages 105–110)

      Mitchell L. Shiffman and Yves Benhamou

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12066

    15. You have free access to this content
    16. You have free access to this content
    17. You have free access to this content
      The role of HBsAg quantification for monitoring natural history and treatment outcome (pages 125–132)

      Michelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah and Patrick Marcellin

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12075

    18. You have free access to this content
    19. You have free access to this content
    20. You have free access to this content
    21. You have free access to this content
      Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon? (pages 157–163)

      Pietro Lampertico, Mauro Viganò and Massimo Colombo

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12064

    22. You have free access to this content
      Management of acute hepatitis B and reactivation of hepatitis B (pages 164–175)

      Ankur Jindal, Manoj Kumar and Shiv K. Sarin

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12081

    23. You have free access to this content
      Treatment of HBV related cirrhosis (pages 176–181)

      Florian van Bömmel and Thomas Berg

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12074

    24. You have free access to this content
    25. You have free access to this content
    26. You have free access to this content
    27. You have free access to this content
      Hope for the eradication of HCV worldwide (pages 198–199)

      Jean-François Delfraissy

      Version of Record online: 3 JAN 2013 | DOI: 10.1111/liv.12077

SEARCH

SEARCH BY CITATION